Inspire Medical Systems, Inc. INSP
61.10 USD +0.56 (+0.93%)
At closeNov 13, 2026, 4:05 PM EST
61.10 0.00 0.00%
After hours · Nov 13, 4:05 PM ET
60.12 Day range 61.47
38.91 52-week range 147.03
- YTD
- -33.75%
- 1 year
- -29.59%
News
benzinga.com Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Lowers Price Target to $93 Freedom Capital Markets analyst Keith Hinton maintains Inspire Medical Systems (NYSE:INSP) with a Buy and lowers the price target from $97 to $93.
zacks.com Here's Why You Should Retain INSP Stock in Your Portfolio for Now Inspire Medical's strong Inspire V adoption, improving reimbursement clarity and patient access initiatives support growth despite near-term headwinds.
zacks.com INSP Is Up 12.1% in Three Months: Can Its Rally Continue From Here? Inspire Medical shares have rallied 12.1% in three months, but reimbursement hurdles and weak revenues raise questions about whether the gains can continue.
seekingalpha.com Inspire Medical Systems: The Moat Just Passed Its Worst-Case Stress Test Inspire Medical Systems remains fundamentally strong despite severe reimbursement and coding disruptions, which the market has mispriced as permanent impairment. INSP's gross margin expanded to 86%,…
globenewswire.com Inspire Medical Systems, Inc. to Present at the Stifel 2026 Healthcare Conference MINNEAPOLIS, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative,…
benzinga.com JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $65 JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $60 to $65.
benzinga.com Truist Securities Reiterates Hold on Inspire Medical Systems, Lowers Price Target to $76 Truist Securities analyst Richard Newitter reiterates Inspire Medical Systems (NYSE:INSP) with a Hold and lowers the price target from $78 to $76.- benzinga.com Wells Fargo Maintains Equal-Weight on Inspire Medical Systems, Raises Price Target to $69 Wells Fargo analyst Larry Biegelsen maintains Inspire Medical Systems (NYSE:INSP) with a Equal-Weight and raises the price target from $56 to $69.
benzinga.com Evercore ISI Group Maintains In-Line on Inspire Medical Systems, Lowers Price Target to $60 Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a In-Line and lowers the price target from $72 to $60.
benzinga.com Barclays Maintains Underweight on Inspire Medical Systems, Lowers Price Target to $62 Barclays analyst Christopher Pasquale maintains Inspire Medical Systems (NYSE:INSP) with a Underweight and lowers the price target from $65 to $62.
benzinga.com These Analysts Increase Their Forecasts On Inspire Medical After Strong Q3 Results Inspire Medical Systems, Inc. (NYSE:INSP) reported upbeat earnings for the third quarter on Monday.
benzinga.com These Analysts Increase Their Forecasts On Inspire Medical After Strong Q3 Results Inspire Medical beat Q3 earnings and sales estimates, narrowed FY2026 guidance, while analysts raised price targets to $77 and $70.- benzinga.com Piper Sandler Maintains Neutral on Inspire Medical Systems, Raises Price Target to $70 Piper Sandler analyst Adam Maeder maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $60 to $70.
benzinga.com Baird Maintains Neutral on Inspire Medical Systems, Raises Price Target to $77 Baird analyst Mike Polark maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $73 to $77.
seekingalpha.com Inspire Medical Systems, Inc. (INSP) Q3 2026 Earnings Call Transcript Inspire Medical Systems, Inc. ( INSP ) Q3 2026 Earnings Call November 2, 2026 5:00 PM EST Company Participants Timothy Herbert - Founder, Chairman, CEO & President Matthew Osberg - Executive VP & CFO…
marketbeat.com Inspire Medical Systems Q3 Earnings Call Highlights Inspire Medical Systems NYSE: INSP reported third-quarter revenue of $206.7 million, down 7.9% from a year earlier but up 3% sequentially, as stronger-than-expected U.S. performance offset weaker…
zacks.com Inspire Medical Systems (INSP) Q3 Earnings and Revenues Beat Estimates Inspire Medical Systems (INSP) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.38 per share a year ago.
zacks.com Here's What Key Metrics Tell Us About Inspire (INSP) Q3 Earnings The headline numbers for Inspire (INSP) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street…
benzinga.com Inspire Medical Systems Q3 2026 Earnings Call Transcript Inspire Medical Systems (NYSE:INSP) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
benzinga.com Inspire Medical Systems Q3 Adj. EPS $0.14 Beats $0.09 Estimate, Sales $206.695M Beat $204.304M Estimate Inspire Medical Systems (NYSE:INSP) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.09 by 55.56 percent. This is a 63.16 percent decrease over earnings…- benzinga.com Inspire Medical Systems Narrows FY2026 Adj EPS Guidance from $1.05-$1.45 to $1.20-$1.40 vs $1.25 Est; Narrows FY2026 Sales Guidance from $835.000M-$875.000M to $850.000M-$860.000M vs $853.615M Est Inspire Medical Systems (NYSE:INSP) narrows FY2026 Adj EPS guidance from $1.05-$1.45 to $1.20-$1.40 vs $1.25 analyst estimate. Narrows FY2026 sales outlook from $835.000 million-$875.000 million to…
globenewswire.com Inspire Medical Systems, Inc. Announces Third Quarter 2026 Financial Results MINNEAPOLIS, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the Company), a medical technology company focused on the development and commercialization of…
zacks.com INSP Stock Gains 47.8% in Three Months: What's Driving the Rally? Inspire Medical Systems gains 47.8% in three months as improved reimbursement clarity, an earnings beat, $30 million in annual savings and new CPT codes boost recovery prospects.- benzinga.com Truist Securities Maintains Hold on Inspire Medical Systems, Raises Price Target to $78 Truist Securities analyst Richard Newitter maintains Inspire Medical Systems (NYSE:INSP) with a Hold and raises the price target from $62 to $78.
gurufocus.com Inspire Medical Systems Inc (INSP) Stock Up 3.3% and Still Undervalued -- GF Score: 64/100 On October 09, 2026, Inspire Medical Systems Inc (INSP) shares rose 3.3% to $68.89, navigating a volatile 52-week range of $38.91 to $147.03. The stock's recent- benzinga.com Barclays Initiates Coverage On Inspire Medical Systems with Underweight Rating, Announces Price Target of $65 Barclays analyst Christopher Pasquale initiates coverage on Inspire Medical Systems (NYSE:INSP) with a Underweight rating and announces Price Target of $65.
gurufocus.com Roche Diagnostics delivers laboratory equipment to support Ebola testing in DRC Roche Diagnostics delivers laboratory equipment to support Ebola testing in DRCPR NewswireJOHANNESBURG, Oct. 7, 2026Roche Diagnostics has provided two molecular
globenewswire.com Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026 MINNEAPOLIS, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2026 after the close of trading on Monday,…
zacks.com Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation INSP gains new Category I CPT codes for Inspire V procedures, creating a dedicated coding framework effective Jan. 1, 2028.
benzinga.com Inspire Medical Systems Receives American Medical Association CPT Editorial Panel Approval To Establish New Set Of Current Procedural Terminology Codes Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with…
globenewswire.com Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel MINNEAPOLIS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative,…- benzinga.com RBC Capital Maintains Sector Perform on Inspire Medical Systems, Raises Price Target to $75 RBC Capital analyst Kendall Au maintains Inspire Medical Systems (NYSE:INSP) with a Sector Perform and raises the price target from $60 to $75.
zacks.com Here's Why You Should Retain INSP Stock in Your Portfolio for Now Inspire Medical is navigating a major product transition as clinical evidence, patient access efforts and reimbursement progress support growth prospects.
benzinga.com Microsoft To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Monday Analysts raised targets for INSP, SECZ, CLF and WAT, while cutting targets for CRDO, CL and TTMI; ratings remained unchanged.- benzinga.com Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Raises Price Target to $97 Freedom Capital Markets analyst Keith Hinton maintains Inspire Medical Systems (NYSE:INSP) with a Buy and raises the price target from $71 to $97.
gurufocus.com Is It Too Late to Buy Inspire Medical Systems Inc (INSP) After 5.5% Rally? GF Value Says Undervalued On September 18, 2026, Inspire Medical Systems Inc (INSP) shares rose 5.5% to a current price of $76.78. This price remains significantly below its 52-week high
defenseworld.net Hsbc Holdings PLC Has $274,000 Stock Holdings in Inspire Medical Systems, Inc. $INSP Hsbc Holdings PLC trimmed its position in shares of Inspire Medical Systems, Inc. (NYSE: INSP) by 68.4% in the undefined quarter, according to the company in its most recent Form 13F filing with the…
zacks.com Zacks Industry Outlook Medical Systems, American Well and Butterfly Network Medical Systems, American Well and Butterfly Network have been highlighted in this Industry Outlook article.- benzinga.com Stifel Maintains Buy on Inspire Medical Systems, Raises Price Target to $80 Stifel analyst Jonathan Block maintains Inspire Medical Systems (NYSE:INSP) with a Buy and raises the price target from $75 to $80.
benzinga.com Top 3 Health Care Stocks That Are Ticking Portfolio Bombs Inspire Medical, Cybin and Aveanna show overbought RSI readings above 70, signaling potential momentum warnings for healthcare investors.- benzinga.com JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60 JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $54 to $60.
- benzinga.com Mizuho Maintains Outperform on Inspire Medical Systems, Raises Price Target to $65 Mizuho analyst Anthony Petrone maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and raises the price target from $55 to $65.
- benzinga.com Oppenheimer Upgrades Inspire Medical Systems to Outperform, Announces $85 Price Target Oppenheimer analyst Suraj Kalia upgrades Inspire Medical Systems (NYSE:INSP) from Perform to Outperform and announces $85 price target.
- benzinga.com Truist Securities Reiterates Hold on Inspire Medical Systems, Raises Price Target to $62 Truist Securities analyst Richard Newitter reiterates Inspire Medical Systems (NYSE:INSP) with a Hold and raises the price target from $54 to $62.
benzinga.com Caterpillar, Wayfair, Zebra Technologies, Gartner And Other Big Stocks Moving Higher On Tuesday US stocks rose, with Dow Jones gaining 500 points on Tue.Caterpillar Inc (CAT) shares surged 8.3% on better-than-expected earnings. Other stocks recording gains include IBTA, BLZE, AMRC, W, VOYG,…- benzinga.com Evercore ISI Group Maintains In-Line on Inspire Medical Systems, Raises Price Target to $54 Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a In-Line and raises the price target from $40 to $54.
benzinga.com Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results INSPI beats expectations, raises FY26 guidance. Analysts raise price targets to $59 & $60. Stock jumps 14.6% in pre-market trading. #INSP
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday's pre-market session. The company's market cap stands at $4.3 million. Adagio Medical Holdings…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Ensysce Biosciences (NASDAQ:ENSC) stock rose 118.1% to $0.61 during Monday's after-market session. The market value of their outstanding shares is at $3.8 million. TransCode Therapeutics…
benzinga.com Nasdaq 100 Tops 28,000, Intel Rallies 13%: Stock Market Today The Nasdaq 100 surged past 28,000 during Tuesday morning trading, setting a fresh record as AI-driven gains in semiconductor stocks continued to power the broader tech sector, defying pressure from…